Physician

Rajiv Ramesh Rathod, MD

According to 2025 Medicare claims, Rajiv Rathod, MD (NPI: 1821201351) practices ophthalmology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is ORANGE COUNTY RETINA MEDICAL GROUP (NPI: 1750398863; TIN: 33-0688181) and primary practice location at 92705-6504.

Rathod's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,292 traditional Medicare patients, billed 67,009 HCPCS/CPT codes, and received $4,808,196 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,305 prescription claims across 358 beneficiaries totaling $158,968 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 75 records totaling $54,754. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,733,090 to $4,808,196. Similarly, Part D prescription costs have risen steadily, from $82,504 to $158,968. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.8M2015 Medicare payment: $1,733,090 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,865,189 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,437,513 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,606,310 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,021,136 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,026,909 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,836,207 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,105,504 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,340,830 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,808,196 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201564210,891$1,733,090
201668411,699$1,865,189
201792214,494$2,437,513
20181,04516,745$2,606,310
20191,09018,983$3,021,136
20201,00015,250$3,026,909
20211,18818,315$3,836,207
20221,23019,705$4,105,504
20231,26129,165$4,340,830
20241,29267,009$4,808,196

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$95K$191K2015 Drug cost: $82,504 (USD; Tot_Drug_Cst)2016 Drug cost: $148,805 (USD; Tot_Drug_Cst)2017 Drug cost: $139,005 (USD; Tot_Drug_Cst)2018 Drug cost: $117,803 (USD; Tot_Drug_Cst)2019 Drug cost: $149,180 (USD; Tot_Drug_Cst)2020 Drug cost: $167,230 (USD; Tot_Drug_Cst)2021 Drug cost: $172,272 (USD; Tot_Drug_Cst)2022 Drug cost: $190,543 (USD; Tot_Drug_Cst)2023 Drug cost: $181,903 (USD; Tot_Drug_Cst)2024 Drug cost: $158,968 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015130436$82,504
2016131501$148,805
2017192706$139,005
2018211777$117,803
2019238941$149,180
2020235926$167,230
2021242944$172,272
20222931,023$190,543
20233291,135$181,903
20243581,305$158,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2052,166$661
92014Established patient complete exam of visual system1,1423,343$100
67028Injection of drug into eye3532,450$96
92134Imaging of retina1,2813,844$33
92201Extended exam of the back part of the eye with retinal drawing1,2833,723$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost442,354$21,189
RestasisCyclosporine15810$16,566
TyrvayaVarenicline Tartrate17540$11,129
CombiganBrimonidine Tartrate/Timolol311,999$10,225
Prednisolone AcetatePrednisolone Acetate2368,645$8,966

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.68$18,086Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.7$36,668Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rajiv Ramesh Rathod, MD?

Tedicare shows public-source Medicare data for Rajiv Ramesh Rathod, MD (NPI 1821201351), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajiv Ramesh Rathod, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajiv Ramesh Rathod, MD?

Rajiv Ramesh Rathod, MD is linked to ORANGE COUNTY RETINA MEDICAL GROUP (billing NPI 1750398863) in the available physician profile data.

Does Rajiv Ramesh Rathod, MD have Open Payments data?

Rajiv Ramesh Rathod, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.